CD8A and neoplasm: Aside from increasing CD8+ T‐cells and CD4+ T‐cells, the combination therapy had already started displaying the highest number of tumor‐infiltrating NK cells by day 6, clearly exhibiting this trend by day 12 (Fig. 4C).